| TREOSULFAN (has an active metabolite) 
| TREOSULFAN | ATC L01AB02
ANTINEOPLASTIC ALKYLATING DRUG FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLOHSCT) ACUTE MYELOID LEUKEMIA (AML) MYELODYSPLASTIC SYNDROME (MDS) | INTRAVENOUS | VD 41 LITER PPB 0 PERCENT HT 1.7 HOUR SOLUBILITY SOLUBLE IN WATER | DNA | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |